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Chaperonins mediate protein folding in a cavity formed by multisubunit rings. The human CCT has eight
non-identical subunits and the His147Arg mutation in one subunit, CCT5, causes neuropathy. Knowledge
is scarce on the impact of this and other mutations upon the chaperone’s structure and functions. To make
progress, experimental models must be developed.We used an archaeal mutant homolog and demonstrated
that the His147Arg mutant has impaired oligomeric assembly, ATPase activity, and defective protein
homeostasis functions. These results establish for the first time that a human chaperonin gene defect can be
reproduced and studied at themolecular level with an archaeal homolog. Themajor advantage of the system,
consisting of rings with eight identical subunits, is that it amplifies the effects of a mutation as compared
with the human counterpart, in which just one subunit per ring is defective. Therefore, the slight deficit of a
non-lethal mutation can be detected and characterized.
M
olecular chaperones are indispensable cellular components that assist folding and assembly of newly
synthesized proteins, translocation of proteins across membranes, as well as refolding and degrading of
misfolded and aggregated proteins1. A class of chaperones, the chaperonins (Cpns) are large, hollow,
ATP-dependent nanomachines that promote correct folding of a wide range of proteins2–7. Cpns are divided into
two groups: group I Cpns, represented byGroEL/GroES, in bacteria, mitochondria and chloroplasts, and group II
Cpns, occurring in eukaryotes and archaea8–10. They share similar quaternary structures consisting of a double
toroid cylinder assembled into two rings stacked back to back. This arrangement generates two dynamic internal
cavities that allow unfolded proteins to fold correctly in a confined environment that opens and shuts in a cycle
powered by ATP hydrolysis11,12. Group I Cpns are composed of 14 identical subunits arranged in two heptameric
rings and require a co-chaperone, GroES, to facilitate protein folding. The Group II Cpns, which are very similar
in Archaea and Eukarya, form double rings with an eight or nine fold rotary symmetry and have built-in lids to
function without a co-chaperone13–15.
The human CCT (chaperonin containing TCP1) is a complex assembly of eight similar but nonidentical
subunits which functions to fold non-native proteins through the alternative opening and closing of the two
chambers. By contrast, many hyperthermophilic Archaea, including Pyrocococcus furiosus and several groups
such as Pyrodictium,Methanopyrus, and Pyrobaculum spp have a single group II Cpn subunit. The double ring of
these archaea is therefore composed of 16 identical subunits and isminimally complex16. Hyperthermophile Cpns
are exceptionally stable in vitro17, affording a suitablemodel for studying oligomerization of group II Cpns such as
the human CCT complex.
Mutations in human Group II CCT subunits 4 and 5 cause rare debilitating diseases18–20. For example, the
His147Arg mutation in human CCT5 causes mutilating peripheral sensory neuropathy20. Little is known con-
cerning the pathogenic mechanisms of these CCT mutations at the molecular level, and on the impact of the
mutations upon the structure and function of the complex. Mutations that allow survival of the carriers are likely
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to have very subtle mechanistic deficits since major functional dis-
ruption would be lethal due to the critical and multiple roles of this
ubiquitous chaperone. Therefore, pathogenic mutations with living
phenotypes have to be considered a priori difficult to characterize at
the molecular level with the systems available today. Ways must be
found to amplify a defect to make it measurable. For this purpose, we
focused on modeling the CCT5 mutation, using the Cpn60 from
Pyrococcus furiosus (Pf), which has only one subunit homolog that
assembles into a hexadecameric double-ring complex like the human
counterpart21.
Results
Our strategy to use the CCT homolog from a hyperthermophile was
based on the conservation of the sequence and inferred structure of
the human CCT5 and the archaeal subunit shown in Fig. 1 (see also
Supplementary Fig. S1). The colinearity of the alignment and the
high similarity of the sequences suggest that the double-ring struc-
ture would be a simplified version (homo-oligomer) with functional
equivalence to the extremely complex (hetero-oligomer) human
CCT hexadecamers. The archaeon Pyrococcus furiosus grows optim-
ally at 100uC. In a previous study we have characterized a C-terminal
structural motif that is a major determinant of extreme thermal
stability. Deletion or modification of this sequence does not disrupt
the hexadecameric structure, but ‘‘detunes’’ the activity without loss
of ATPase or protein folding properties22. The deletion of 22 amino
acids from the C-terminus of the Pf Cpn60 removes the ‘‘modulator
domain’’ that controls thermostability in this exceptionally thermo-
stable protein. Consequently, the thermal stability andTmax for activ-
ity are downgraded to 50uC. In Fig. 1, the alignment of the archaeal
Cpn60 (PfCD) and the human CCT5 shows that there is strong
conservation between these polypeptides. The human CCT5 has
44% amino acid sequence identity and 65% similarity with PfCD.
The amino acid His147 in CCT5 matches Ile138 in PfCD and the
upstream and downstream sequences show conservation and
colinearity.
Structural representations of the human CCT5 and PfCD were
generated in the Swiss-Model server, using their primary amino-acid
sequences and as template the crystal structure of the Cpn60 a sub-
unit from Thermococcus KS-1 (KS-1a; PDB ID: 1Q3Q), which was
crystallized with an ATP analogue, AMP-PNP, and fluoride ion in
the active site23. Overall structural similarities and characteristic fea-
tures of group II chaperonins are evident around the equatorial
domain (Fig. 2A). This domain comprises the ATP/ADP binding
site, is the region where the mutation H147R occurs in the case of
the human CCT5-associated neuropathy, and is essentially super-
imposed. Noteworthy, the a-helixes in which are located His147 in
CCT5, or Ile138 in PfCD overlap, and the side chain of His147 of
human CCT5 and Ile138 of PfCD showed the same configuration as
Ile138 of KS-1a. To analyze the structural consequences of mutation
I138R in PfCD, we superimposed the PfCD structure onto the crystal
structure of the KS-1a (1Q3Q) (Fig. 2B). The mutation I138R is
located in the equatorial domain, in the N-terminus of Cpn, and this
position is close to the intermediate domain, which serves as a hinge
to allow binding of ATP/ADP when the apical alpha-helical protru-
sion domain of Cpn recognizes client proteins24. Arg138 is contigu-
ous to the conserved motif Gly94-Thr99 constituting the ATP
binding site in group II chaperonins25, suggesting that steric hind-
rance might impede the conformational change necessary for ATP
binding. A similar situation is apparent in the case of mutant human
CCT5 with Arg147, instead of His147 (Fig. 2C).
In Fig. 3, the optimal temperatures for ATPase activity of the Pf
Cpn wild type as well as 1138H and I138R were shown to be 50uC.
The PfCD and I138H Cpns showed much higher ATPase activities
than I138RCpn over thewhole temperature range investigated. Fig. 3
also shows that the residual activity of I138R Cpn was,12% of that
of PfCD, whereas I138H retained ,88% of ATPase activity com-
pared with PfCD. These data indicate that Arg located at position 138
caused the loss of ,88% of the total ATPase activity displayed by
PfCD.
Fig. 4 shows the wild type, I138H and I138R complexes separated
on a 4–9% gradient native-PAGE gel. Group II Cpns typically form
double-ring hexadecamers, the quaternary structures of group II
Cpn, consisting of a double toroid cylinder assembled into two rings
of subunits stacked back-to-back. This conformation is optimal for
Figure 1 | The N-terminal portion of the amino-acid sequence alignment of human CCT5 (uniprot ID; P48643) and Pyrococcus furiosus PfCPN
(uniprot ID;Q8TZL6) (A) with a 22-amino acids deletion inC-terminus, named PfCD (see B). For a complete alignment see Supplementary Fig. S1. The
residues conserved between human CCT5 and PfCD are shown in the space between their sequences. The secondary structures were predicted using the
GOR IV server (http://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page5npsa_gor4.html), and a-helix, b-sheet, and loop elements are represented as red
rings, blue wave, and black line, respectively, above or below their amino-acid sequences. The amino acids matching the human pathogenic mutation in
CCT5 (His147) and the equivalent locus in the archaeal PfCD (Ile138) that we mutated to Ile138His and Ile138Arg - the humanized archaeal molecules -
are shown in red bold letters and indicated with an asterisk.
www.nature.com/scientificreports
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Figure 2 | (A). Human CCT5 and P. furiosus PfCD superposed onto the crystal structure of Thermococcus strain KS-1 a. LEFT: The structure (Swiss-
Model (http://swissmodel.expasy.org/) of PfCD (gold) superposed onto the crystal structure of KS1a (momomers, displayed in marine blue, violet, and
deep teal as surface, and in cyan color as ribbon). The hexadecamer, double-ring structure, is depicted by a dotted line, as is on the right of the subsequent
panels B and C. RIGHT:Magnified image of the superposed structures of the PfCD (gold) and Human CCT5 (orange) onto KS1a; cyan ribbon). Side
chains of isoleucine at 138 of PfCD (blue) and isoleucine at 138 of KS1a (deep teal), and side chain of histidine at 147 of human CCT5 (red) are
represented as ball and stick. AMP-PNP (green stick; also shown on the left in panels B and C) and magnesium ion (yellow ball). (B). PfCD around the
Arg138 mutation and its predicted matching areas in the crystal structure of KS1a. LEFT: Mutant Arg138 (orange) and its adjacent Arg421 (red) in the
opposite a helix are drawn with stick in the PfCD structure (marine blue). RIGHT: Arg138 mutation area was superposed onto the crystal structure of
KS1a (monomers are displayed in various shades of blue). (C). Human CCT5 structure around the Arg147 mutation viewed from different angles and
predicted matching areas in the crystal structure of KS1a. LEFT: Wild-type His147 (blue), mutant Arg147 (red) and their adjacent amino acids, Ser428
and Cys429 (magenta) in the opposite a helix are drawn with ball and stick and transparent surface in the human CCT5 structure (orange ribbon).
RIGHT:The predicted Arg147mutation area in themonomers is shown as a red surface on the crystal structure of KS1a (monomers are shown as surface
in marine blue, violet, deep teal, and cyan colors.
www.nature.com/scientificreports
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promoting correct folding of non-native cellular proteins22. Whereas
there was no clear difference in molar concentration ratios of hex-
adecamer between PfCD and I138H, a relatively lower concentration
of double-ringed Cpn was observed in the case of I138R (Fig. 4, top
panel). Densitometric analysis revealed that I138 formed double ring
approximately 4–6 fold less than PfCD or I138H, indicating a func-
tional deficit in maintaining the double ring structure (results not
shown).
Fig. 5 shows that protection against heat denaturation of two
enzymes by PfCD and its mutants is lower for I138R as compared
with I138H and PfCD when hetero-oligomeric preparations are
tested. However, hexadecamers of all three variants of the chapero-
nin, freshly purified by gel permeation chromatography, all showed
intact heat protection activity. The enzymes tested at various tem-
peratures were porcine mitochondrial malate dehydrogenase
(MDH) and shrimp alkaline phosphatase (SAP). The results with
hetero-oligomeric preparations, incubated with MDH at 37 or
42uC are shown in panels A and B, respectively, while the results
with freshly purified hexadecamers are shown in panels C (MDH, at
37uC) and D (SAP, at 50uC).
In Fig. 6, the ability of the archaeal Cpn60 to deconstruct and
disperse amyloid fibrils under mild conditions, a system that has
been described in detail elsewhere26, is confirmed. The top panel
shows the activity of the PfCD Cpn60 to disrupt fibrils completely
in 30 min. The activity of the I138H mutant is similar to PfCD
(middle panel), whereas the I138Rmutant is defective, and the fibrils
are intact at 60 min (bottom panel).
Since the study of the activity of pure monomers was not feasible
because of their strong tendency to oligomerize, their response to
heat stress was examined in silico, via simulations. The results are
shown in Fig. 7 and the overall conclusions from these analyses are
displayed in Table 1. It can be seen that the archaeal chaperonin with
optimal temperature at 42uC, or higher, is rigid (it loses flexibility) at
37uC, a stressful temperature for this molecule. Similarly, CCT5 is
flexible at its physiological temperature of 37uC but is rigid, i.e., it
loses flexibility, at the stressful temperature of 42uC. It can also be
seen that the Arg mutations in both the archaeal and the human
chaperonins, result in a loss of flexibility in the two molecules, even
at their respective optimal temperatures.
Discussion
Human TRiC/CCT is a double-ring complex that interacts with
,10% of the human cytosolic proteins and is essential to achieve
folding and stabilization of many essential proteins in human27 and
yeast28. In addition, TRiC modulates and suppresses the aggregation
of neurologically toxic proteins with polyglutamine motifs29,30. We
have set out to model the function of mutant forms of the TRiC
hexadecamer using an archaeal Cpn60 homolog with high sequence
and structural homology to CCT5 (Fig 1). As shown in Fig. 2, when
the modeled CCT5 structure was superimposed onto the crystal
structure of the Cpn60 subunit from the archaeal Cpn60, they
showed overall structural similarities and characteristic features of
group II chaperonins around the equatorial domain (Fig. 2A),
including the ATP/ADP binding site, which is the region where
the mutation His147Arg occurs in the case of the human CCT5-
associated neuropathy. Remarkably, the a-helixes that include
His147 in CCT5, and Ile138 in PfCD overlap, and the side chain of
His147 of human CCT5 and Ile138 of the archaeal model colocated
with Ile138. Assuming that His 147 was the wild type residue at the
position of the mutation causing the peripheral sensory neuropathy,
we mutated Ile138 to His to recreate the human structural element
and tested the effect on chaperone stability and function in vitro.
H138R is located in the equatorial domain, near the N-terminus,
close to the intermediate domain, which serves as a hinge with a
large articulation angle, to allow binding of ATP/ADP when the
apical alpha-helical protrusion domain of Cpn recognizes client pro-
teins24. Interestingly, our I138R structure representation revealed
Figure 3 | ATPase activities of PfCD, I138H, and I138R Cpns at various
temperatures. PfCD (red square), I138H (green triangle), I138R (purple
star). The results shown are mean values (6SD) of triplicate experiments. Figure 4 | Oligomeric states of purified PfCD, I138H, and I138R Cpns
determined by gel filtration chromatography (top panel) and
corresponding SDS-PAGE analysis (bottom panel). PfCD, or I138H, or
I138R purified by gel filtration chromatography followed by anion
exchange chromatography were pooled together for ATPase activity and
MDH heat-protection activity assays. The same amounts of these pooled
pure Cpn proteins were subjected to 4–9% gradient native-PAGE analysis
(top panel) and 12% SDS-PAGE analysis (bottom panel) and then stained
withCoomassie brilliant blue G-250. The figures to the right, 16 on top and
1 at the bottom, indicate hexadecamer and monomer, respectively, while
the other oligomers are distributed in between them as shown by the gel
bands. The thick arrow at the very bottom indicates the monomeric band
of the purified Cpns run with same amount of protein in SDS-PAGE. St,
molecular weight standard.
www.nature.com/scientificreports
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that the Arg138 mutation formed a close contact with a neighboring
Arg421 in the adjacent a-helix. It seems that the side chain of Arg
could cause a steric hindrance through the repulsive effects of closing
the distance between two internal positive charges, thus affecting the
helix-helix interface (Fig. 2C). Arg138 is contiguous to the highly
conserved motif Gly94-Thr99 for ATP binding in group II chaper-
onins25, suggesting steric hindrancemight impede the necessary con-
formational change for ATP binding.
Figure 2 also shows that the ‘‘humanized’’ version had little effect
on the structure and function of the complex. In contrast, the muta-
tion I138R (Fig. 2C), sharply reduced the catalytic capability result-
ing in low ATPase activity, and poor heat protection of mesophilic
vertebrate enzymes. The quaternary structures of group II chaper-
onins, consisting of two rings of subunits stacked back to back, were
determined on a gradient native-PAGE gel shown in Fig. 4, similar to
analysis of assembly deficient N terminal mutants22. Interestingly,
whereas there was no difference in molar concentration ratios of
hexadecamer in preparations of PfCD, or I138H, double-ringed
Cpn at ,1 mDa was sharply reduced in the case of I138R (Fig. 4,
top panel). Densitometric analysis revealed that I138R formed less
than 20% of double rings than PfCD or I138H indicating a functional
deficit in maintaining the double ring structure (Supplementary
material).
We have previously characterized the C-terminus as a primary
thermostability determinant, which can be tuned to achieve lower
temperatures for optimal activity of the archaeal Cpn6022. Thus, the
Cpn60 complex from the hyperthermophile Pyrococcus furiosus
(Topt for growth 100uC), which was originally active and stable at
95uC, was lowered to 50–55uC by the deletion of the C-terminus.
Thus detuned, the Cpn60 can be used for refolding and salvage of
mesophilic enzymes such as porcine mitochondrial MDH as shown
in Fig. 5. Porcine MDH is known to lose activity rapidly at 51uC31.
Incubation at 50uC in the absence of Cpn resulted in rapid first-order
loss of MDH activity (t1/2: 13 min). Both the PfCD and I138H Cpns
were effective in protecting MDH against heat-denaturation at both
42 and 50uC compared to unprotected MDH (Figs 5A, and B,
respectively). By contrast, I138R showed drastically diminished
inhibition of heat-denaturation of MDH (t1/2: 36 min), as indicated
Figure 5 | MDH heat-protection activity profiles of mixed oligomers of PfCD, I138H, and I138R Cpns at 376C (A) and 426C (B); and MDH heat-
protection activity profiles at 376C (C) and SAP heat-protection activity profiles at 506C (D) of pure hexadecameric Cpns.MDH (or SAP, in panel D)
residual activities in the presence of PfCD (red square), I138H (green triangle), or I138R (purple star). Negative control, MDH (or SAP in panel C)
residual activity without any Cpn (blue diamond). The results shown are mean values (6SD) of triplicate experiments.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 4 : 6688 | DOI: 10.1038/srep06688 5
by,8.9-fold decrease in the half-life (t1/2) compared to that of MDH
protected by PfCD and I138H. At 42uC a similar trend was observed:
PfCD: t1/2: 17.05 min, I138H t1/2: 15.05 min, I138R t1/2: 5 min, no
Cpn t1/2: 2.7 min). Similar results were obtained with SAP at 50uC
(Fig. 5D). We conclude that defective oligomerization leads to
impaired chaperoning functions of the archaeal Cpn60 and that
the human TRiC complex would likely display a similar effect.
Recent work has implicated TRiC as a critical defense strategy
forestalling the formation of amyloid aggregates of proteins that
cause devastating neurological deficits in Parkinson’s and
Huntington’s syndromes29,30. Our group has recently constructed
archaeal Cpn60 mutants to model the disaggregation and dispersal
of amyloid fibrils under physiological conditions32. In Fig. 6 we show
the rapid dispersal of amyloid fibrils by both the PfCD and His138
mutant chaperonin oligomers, as we have reported previously. The
Arg138 mutant was completely inactive in this assay, which reflects
the ability of the chaperonins to deconstruct extremely stable cross-
beta structures. In past studies we have shown that highly stable and
toxic prion fibrils can also be dispersed in a similar assay33. Fig. 7
confirms that the presence of Arg in place of His leads to a loss of
flexure and we speculate that this results in decreased induced fit
interaction during assembly.
The findings fromMD simulation summarized in Table 1 are that
stress, i.e., 37uC for PfCpn and 42uC for CCT5, causes loss of flex-
ibility, and the same effect is caused by the His-to-Arg mutation,
which is apparent at the optimal temperatures for the twomolecules,
i.e., 37uC for CCT5, and 42uC for PfCpn.
It can be assumed that the devastating phenotypic effects of this
mutation, which required peripheral amputation in some homo-
zygous individuals, actually results from a very subtle biochemical
defect due to pivotal role of TRiC in the posttranslational maturation
of many essential proteins. Here, we demonstrate that a homooligo-
meric archaeal model Cpn60 complex, adjusted to fit the human
temperature range, effectively amplifies this slight defect eight-fold
compared to the human TRiC complex, composed of eight noniden-
tical subunits per ring.
Methods
Sequence comparison.The followingmolecules were studied and compared:Human
CCT5 (CCT5) wild type (His147) and its mutant CCT5 Arg147 (His147Arg);
Pyrococcus furiosus Chaperonin 60 with Ile138, with the last 22 amino acids deleted
(PfCD)17,34; wild type for this work); PfCD mutant Ile138His, and PfCD Arg138
(His138Arg; equivalent to the human His147Arg mutant).
Homology modelling. The 3D structures of the wild type molecules (PfCD, and
CCT5-His147) and their mutants (PfCD Ile138His, and His138Arg; and CCT5
Arg147) were constructed by homology modeling. This was performed using PRIME
software (PRIME, 2012) and FASTA sequences35. The sequences of CCT5 and PfCD
were retrieved from the Uniprot KB/TrEMBL database35. Basic Local Alignment
Search Tool (BLAST) searches predicted that the crystal structure of the chaperonin
from Thermococcus strain KS-1, PDB code: 1Q3R; resolution-2.9 A˚36, as the most
suitable average structure. Alignments between the template and the target sequences
were performed using ClustalW 2.0 with default parameters37. The structures of all
proteins were generated using the PRIMEmodule (PRIME, version 3.1, Schro¨dinger,
LLC, New York, NY, 2012). The generated models were relaxed by molecular
dynamic simulations and were further validated.
Chemicals, enzymes and reagents. Restriction endonucleases, Taq polymerase and
DNA ligase were purchased fromNewEngland Biolabs (Beverley,MA).Malate, ATP,
EDTA, DTT, b-NADH and NAD were purchased from Sigma–Aldrich (St. Louis,
MO). Porcine heart malate dehydrogenase (MDH) was purchased from Amresco
(Solon, OH). PageRuler Broad Range unstained protein ladder in SDS-PAGE and
NativeMarkTM unstained molecular weight protein standard were from Thermo
scientific (Rackford, IL) and Invitrogen (Carlsbad, CA), respectively.
Cloning, expression and purification of PfCD, I138H and I138R. The PfCD gene
was amplified from Pyrococcus furiosus genomic DNA using primers containing at
59-PfCD primer with NcoI recognition sequence and 39-PfCD primer with BamHI
recognition sequence listed in Supplementary Table S1 and then this PCR product
was purified using GeneJET PCR purification kit (Thermo scientific) for digestion
with NcoI and BamHI enzymes. The genes encoding PfCD, I138H or I138R were
cloned initially in Escherichia coli DH5a. The pET33b(1) expression vector
(Novagen, Madison, WI) was used for recombinant expression in Escherichia coli
Rosetta(DE3). The cell pellets were re-suspended in exchange binding buffer (25 mM
Hepes–KOH, pH 7.5) fat 25% w/v prior to cell disruption using a French Press. The
soluble fraction was obtained from cell homogenate, clarified by centrifugation at 4uC
prior to anion exchange chromatography and gel filtration chromatography (GFC).
Elution with a 0.2–1M NaCl gradient was used. Peak fractions were purified by gel
permeation using HiPrep Sephacryl S-300 HR column (3 3 55 cm) at a flow rate
1.5 ml/min. To verify homogeneity fractions were run on 12% SDS-PAGE. Protein
concentration was carried out using AmiconH Ultra centrifugal Filter-100,000
MWCO (Merck Millipore, Darmstadt, Germany). Protein concentration was
determined by the Bradford method (Bio-Rad Protein, Hercules, CA). See
Supplementary Figs. S2-S5.
Gradient native-PAGE. For oligomeric pattern analysis of recombinant PfCD,
I138H and I138R, the GFC purified samples were analyzed in 4, 9% gradient native-
PAGE. Stacking and two separating gel buffers with 4 or 9% acrylamide were
prepared without SDS. In preparation of separating gel buffers with 9% acrylamide,
glycerol plus Bromophenol Blue (0.001%) was added to a final concentration of 15%
and vertical acrylamide gradient formed via specific gravity difference between 4 and
9% separating gel during gel solidification. Bromophenol Blue in separating gel
buffers with 9% acrylamide served to visualize the gradient after gel formation.
Purified chaperonins were preheated under ATPase activity assay conditions at 50uC
for 30 min to oligomerize complexes, prior to mixing with PAGE gel sample buffer
without b-mercaptoethanol and SDS. Gradient native gels were run at constant
voltage (20 mV) for 3 h at 23uC and PfCD, I138H and I138R protein bands on native
SDS-PAGE gel were visualized by staining with Coomassie Brilliant Blue R-250. See
Supplementary Figs. S4 and S5.
ATPase activity and heat protection assays using MDH or SAP. The standard
ATPase activity assay reaction buffer composed of 25 mM Hepes–KOH at pH 7.2,
300 mM KCl, 1 mM MgCl2 in the presence or absence of 0.05 mg/ml final
concentration of purified PfCD, I138H or I138R protein in a final volume of 90 ml.
The reaction mixture was preincubated at series of temperatures ranging from 30 to
90uC for 3 min before adding ATP (50 mM) to initiate ATP hydrolysis, as reported
previously22. The reaction proceeded for 15 min at each temperature in a PCR
thermocycler (Bio-Rad), followed by perchloric acid addition to a final concentration
of 2% v/v to quench the reaction. The liberated Pi was determined by the Malachite
Green assay at 630 nm. All reactions and controls were performed under light
mineral oil (Sigma-Aldrich) for avoiding evaporation during reaction. Standard
deviation was calculated from assays repeated three times.
Porcine malate dehydrogenase (MDH) heat protection by PfCD, I138H and I138R
was analyzed by comparing protection activities at 37 or 42uC.MDH samples (1 mg/
ml) were incubated in reaction buffer (25 mM Hepes-KOH, pH 8.0, 300 mM KCl,
1 mMMgCl2 and 0.5 M ammonium sulfate) plus 4 mMATP at each temperature in
the presence or absence of Cpn (0.2 mg/ml). Residual MDH enzyme activities after
different incubation time intervals (0, 3, 6, 9, 12 and 15 min at 37uC and 0, 1, 2, 3, 4
and 5 min at 42uC) were measured immediately as described39 at 25uC in modified
assay mixture (90 mM Hepes–KOH, pH 8.0, 0.22 mM aˆ-NADH, 0.55 mM oxaloa-
cetate (Sigma-Aldrich)). The time dependent oxidation of b-NADHwasmeasured by
recording the decreasing OD 340 nm. To measure residual shrimp alkaline phos-
phatase (SAP) enzyme activity with heat treatment at 50uC, we used r-nitrophenyl
phosphate (pNPP) supported by pNPP Phosphatase Assay Kit (BioAssay Systems,
Hayward, CA). The pNPP is a chromogenic substrate which was converted via SAP to
n˜-nitrophenol was measured at 405 nm under alkaline conditions.
Figure 6 | Dispersion of amyloid fibrils by archaeal PfCD (top strip of
panels), partial dispersion by I138H (middle strip of panels) and lack of
dispersion by I138R (bottom strip of panels).
www.nature.com/scientificreports
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Figure 7 | Root mean square deviation (RMSD) plot of Ca atoms at 310 and 315 K. Top panel: PfCD at 310 K (blue line) and at 315 K (red line). Middle
panel, I138H at 310 K (blue line) and at 315 K (red line); I138R at 310 K (green line) and at 315 K (violet line). Bottom panel: Human CCT5 with H at position
147 at 310 and 315 K (blue and red lines, respectively); Human CCT5 with R at position 147 at 310 and 315 K (green and violet lines, respectively).
www.nature.com/scientificreports
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Fibril dispersion assays and Atomic Force Microscopy. Amyloid fibrils prepared
frombovine insulin (I5500, Sigma-Aldrich) were subjected to dispersion assays by the
chaperonins26,32. Insulin was preincubated at 70uC and pH 2.4 at a concentration of
60 mg/mL for 24 h to prepare mature fibrils. The fibrillation process was terminated
by bringing the sample to 23uC and centrifuging twice at 14,000 g to remove the
unfibrillated fraction. The gelatinous phase containing mature fibrils was then
resuspended in pH 2.4 in HCl and used for dispersion assays.
Samples for fibril dispersion assays by chaperonins were prepared by mixing
chaperonins and fibrils in a,1520 proteinmolar ratio in the presence of 2 mMATP,
1 mM Mg21 and 20 mM sodium acetate buffer pH 6.0. The reaction mixtures were
incubated at 50uC for 60 min, with aliquots taken at 10, 30 and 60 min. In the control
reaction, the chaperonin was replaced by an equal volume of the buffer at 50uC for
60 min followed by imaging.
Samples for Atomic Force Microscopy (AFM) imaging were prepared by diluting
the 10-, 30- and 60-minute aliquots in a 15100 volumetric ratio by 20 mM sodium
acetate buffer pH 6.0, without ATP or Mg21, and depositing on freshly cleaved mica
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